Literature DB >> 21985442

Effect of weight loss on C3 and C4 components of complement in obese patients.

Antonio Hernández-Mijares1, Celia Bañuls, Lorena Bellod, Ana Jover, Eva Solá, Carlos Morillas, Víctor M Víctor, Milagros Rocha.   

Abstract

BACKGROUND: Circulating C3 levels are elevated in obese patients, but how this factor is affected after weight loss through diet is a question that is yet unanswered. Therefore, the aim of this study was to evaluate the effects of weight loss on lipid and hydrocarbonated metabolism parameters and on the levels of C3 and C4 components of complement in obese patients.
DESIGN: This is a longitudinal intervention study based on a 6-week very low-calorie diet (VLCD), a liquid formula of 603 kcal/day. A total of 131 middle-aged patients were distributed among grades II, III and IV of obesity. Anthropometric parameters, total cholesterol, triglycerides, high-density lipoprotein cholesterol, LDLc, apolipoproteins A-I and B-100, glucose, insulin, HOMA-IR and C3 and C4 levels were evaluated at baseline and after 6 weeks of intervention.
RESULTS: After VLCD, the moderate weight loss was accompanied by a significant reduction in C3 levels in grade III and grade IV patients (10.2% and 15.4%, respectively; P < 0.001). C4 levels were not altered. Adherence to the diet improved anthropometric parameters and was accompanied by a significant decrease in all lipid profile parameters (P < 0.001). In addition, weight loss was associated with an improvement in hydrocarbonated metabolism as shown by the decrease in glucose levels and HOMA-IR (P < 0.01).
CONCLUSIONS: Our findings show that in severely obese patients following a VLCD for 6 weeks produces reductions in factor C3, a biomarker of cardiovascular disease, and a significant improvement in some features of metabolic syndrome. In this way, the abovementioned diet may represent an effective strategy for treating obesity and related cardiovascular risk factors.
© 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985442     DOI: 10.1111/j.1365-2362.2011.02606.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  Menopause, complement, and hemostatic markers in women at midlife: the Study of Women's Health Across the Nation.

Authors:  Samar R El Khoudary; Kelly J Shields; Hsiang-Yu Chen; Karen A Matthews
Journal:  Atherosclerosis       Date:  2013-09-05       Impact factor: 5.162

2.  Short- and Long-Term Effects of Weight Loss on the Complement Component C3 After Laparoscopic Gastric Bypass in Obese Patients.

Authors:  Segundo Á Gómez-Abril; Carlos Morillas-Ariño; Jose L Ponce-Marco; Teresa Torres-Sánchez; Fernando Delgado-Gomis; Antonio Hernández-Mijares; Milagros Rocha
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

3.  Hypertriglyceridemia accompanied by increased serum complement component 3 and proteinuria in non-nephrotic chronic kidney disease.

Authors:  Kentaro Kohagura; Masako Kochi; Tsuyoshi Miyagi; Takanori Kinjyo; Yuichi Maehara; Kojiro Kinjyo; Kazufumi Nagahama; Atsushi Sakima; Kunitoshi Iseki; Yusuke Ohya
Journal:  Clin Exp Nephrol       Date:  2013-06-12       Impact factor: 2.801

4.  Systemic inflammation is negatively associated with early post discharge growth following acute illness among severely malnourished children - a pilot study.

Authors:  James M Njunge; Gerard Bryan Gonzales; Moses M Ngari; Johnstone Thitiri; Robert H J Bandsma; James A Berkley
Journal:  Wellcome Open Res       Date:  2021-03-16

5.  Maternal C3 complement and C-reactive protein and pregnancy and fetal outcomes: A secondary analysis of the PEARS RCT-An mHealth-supported, lifestyle intervention among pregnant women with overweight and obesity.

Authors:  Maria A Kennelly; Sarah Louise Killeen; Catherine M Phillips; Gouiri Alberdi; Karen L Lindsay; John Mehegan; Martina Cronin; Fionnuala M McAuliffe
Journal:  Cytokine       Date:  2021-10-23       Impact factor: 3.926

6.  A randomized diet-induced weight-loss intervention reduces plasma complement C3: Possible implication for endothelial dysfunction.

Authors:  Shunxin Jin; Yvo H A M Kusters; Alfons J H M Houben; Jogchum Plat; Peter J Joris; Ronald P Mensink; Casper G Schalkwijk; Coen D A Stehouwer; Marleen M J van Greevenbroek
Journal:  Obesity (Silver Spring)       Date:  2022-07       Impact factor: 9.298

Review 7.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

Review 8.  Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery.

Authors:  Olivier F Noel; Christopher D Still; George Argyropoulos; Michael Edwards; Glenn S Gerhard
Journal:  J Obes       Date:  2016-02-24

9.  Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy.

Authors:  Yan Ouyang; Jingyuan Xie; Meng Yang; Xiaoyan Zhang; Hong Ren; Weiming Wang; Nan Chen
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

10.  Moderate weight loss attenuates chronic endoplasmic reticulum stress and mitochondrial dysfunction in human obesity.

Authors:  Sandra López-Domènech; Zaida Abad-Jiménez; Francesca Iannantuoni; Aranzazu M de Marañón; Susana Rovira-Llopis; Carlos Morillas; Celia Bañuls; Víctor Manuel Víctor; Milagros Rocha
Journal:  Mol Metab       Date:  2018-10-19       Impact factor: 7.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.